ALTO-100 in Major Depressive Disorder

Status:
Recruiting

Trial end date:
2023-05-01

Target enrollment:

Participant gender:

The purpose of this study is to collect biologically-based data for defining predictors and correlates of the effects of ALTO-100.

Phase 2

Alto Neuroscience